Help Therapeutics
PrivateLast Round
Series C
Nov 15, 2021
Total Funding Raised
$35.51M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Help Therapeutics operates in Healthcare & Life Sciences and is based in Nanjing. Its latest recorded funding round was a Series C round in November 2021.
Help Therapeutics is a biotechnology company that develops induced-pluripotent stem cell (iPSC) and mesenchymal stem cell (MSC) technology to treat degenerative diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Precision Medicine, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Infrastructure
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Help Therapeutics Comparables
Compare Help Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Heartseed | 89% | |
| Bayer AG | 82% | |
| iHeart Japan Corporation | 79% |
For institutional investors. Book with your work email.
Help Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Nov 15, 2021 | ||||
| Series A Extension | Oct 15, 2020 | ||||
| Series A | Jun 1, 2016 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Help Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Oriental Fortune Capital | Series A, Angel |
| Legend Star | Series A Extension, Series A, Angel |
| Ming Bioventures | Series C |
| Jinmao Capital | Series C |
| Share Capital | Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors grew 119% MoM, from 646 to 1.4K.
- Jun 3, 2026
Headcount grew 24% QoQ (from 21 to 26 employees)
For institutional investors. Book with your work email.
Help Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Help Therapeutics's valuation, stock price, and market status.
Is Help Therapeutics a public or private company?
Help Therapeutics is a private company.
What is the current stock price of Help Therapeutics?
Help Therapeutics is a private company, so its shares have no public market price. Caplight tracks Help Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Help Therapeutics worth (valuation)?
Valuation information for Help Therapeutics is not publicly available.
Can I buy Help Therapeutics stock?
Help Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Help Therapeutics's last funding round?
Help Therapeutics's most recent funding round was Series C on November 15, 2021.
Who are the main investors in Help Therapeutics?
Key investors in Help Therapeutics include Oriental Fortune Capital, Ming Bioventures.
Will Help Therapeutics IPO soon?
No public IPO plans have been announced for Help Therapeutics.
How can I track Help Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Help Therapeutics's shares on secondary markets.